Last Updated: May 10, 2026

List of Excipients in API ziprasidone


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ziprasidone

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Viatris Specialty LLC GEODON ziprasidone 58151-131 LACTOSE
Viatris Specialty LLC GEODON ziprasidone 58151-131 MAGNESIUM STEARATE
Viatris Specialty LLC GEODON ziprasidone 58151-131 STARCH, CORN
REMEDYREPACK INC ZIPRASIDONE ziprasidone 70518-3376 LACTOSE
REMEDYREPACK INC ZIPRASIDONE ziprasidone 70518-3376 MAGNESIUM STEARATE
ROERIG GEODON ziprasidone hydrochloride 0049-3960 LACTOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing ziprasidone

Company Ingredient NDC Excipient
Major Pharmaceuticals ziprasidone 0904-6269 ALCOHOL
Major Pharmaceuticals ziprasidone 0904-6269 AMMONIA
Major Pharmaceuticals ziprasidone 0904-6269 ANHYDROUS LACTOSE
Major Pharmaceuticals ziprasidone 0904-6269 BUTYL ALCOHOL
Major Pharmaceuticals ziprasidone 0904-6269 FD&C BLUE NO. 1
Major Pharmaceuticals ziprasidone 0904-6269 FD&C RED NO. 3
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for ziprasidone

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: AMMONIUM CHLORIDE

ziprasidone drug variants containing AMMONIUM CHLORIDE

Company Ingredient NDC
Macleods Pharmaceuticals Limited ziprasidone hydrochloride 33342-144
A-S Medication Solutions ziprasidone hydrochloride 50090-5420
A-S Medication Solutions ziprasidone hydrochloride 50090-5785
Bryant Ranch Prepack ziprasidone hydrochloride 63629-3331
Bryant Ranch Prepack ziprasidone hydrochloride 63629-8150
NuCare PharmaceuticalsInc ziprasidone hydrochloride 68071-2979
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM

ziprasidone drug variants containing BETADEX SULFOBUTYL ETHER SODIUM

Company Ingredient NDC
Roerig ziprasidone mesylate 0049-1203
DrReddy's Laboratories Inc ziprasidone mesylate 43598-061
DrReddy's Laboratories Inc ziprasidone mesylate 43598-848
A-S Medication Solutions ziprasidone mesylate 50090-4540
HF Acquisition Co LLC DBA HealthFirst ziprasidone mesylate 51662-1564
Gland Pharma Limited ziprasidone mesylate 68083-340
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM SILICATE

Excipient focus: CARBOXYMETHYLCELLULOSE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 28

Excipient focus: ETHYLCELLULOSE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

ziprasidone drug variants containing FD&C BLUE NO. 2

Company Ingredient NDC
Sandoz Inc ziprasidone hydrochloride 0781-2164
Macleods Pharmaceuticals Limited ziprasidone hydrochloride 33342-144
A-S Medication Solutions ziprasidone hydrochloride 50090-3823
A-S Medication Solutions ziprasidone hydrochloride 50090-5420
A-S Medication Solutions ziprasidone hydrochloride 50090-5785
Proficient Rx LP ziprasidone hydrochloride 63187-168
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

ziprasidone drug variants not containing MAGNESIUM STEARATE

Company Ingredient NDC
Macleods Pharmaceuticals Limited ziprasidone hydrochloride 33342-144
A-S Medication Solutions ziprasidone hydrochloride 50090-5420
A-S Medication Solutions ziprasidone hydrochloride 50090-5785
Bryant Ranch Prepack ziprasidone hydrochloride 63629-3331
Bryant Ranch Prepack ziprasidone hydrochloride 63629-8150
NuCare PharmaceuticalsInc ziprasidone hydrochloride 68071-2979
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: METHANESULFONIC ACID

Excipient focus: POLYETHYLENE GLYCOL

ziprasidone drug variants containing POLYETHYLENE GLYCOL

Company Ingredient NDC
Macleods Pharmaceuticals Limited ziprasidone hydrochloride 33342-144
A-S Medication Solutions ziprasidone hydrochloride 50090-5420
A-S Medication Solutions ziprasidone hydrochloride 50090-5785
Bryant Ranch Prepack ziprasidone hydrochloride 63629-3331
Bryant Ranch Prepack ziprasidone hydrochloride 63629-8150
NuCare PharmaceuticalsInc ziprasidone hydrochloride 68071-2979
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: POLYSORBATE 80

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: SUCROSE

ziprasidone drug variants containing SUCROSE

Company Ingredient NDC
Macleods Pharmaceuticals Limited ziprasidone hydrochloride 33342-144
A-S Medication Solutions ziprasidone hydrochloride 50090-5420
A-S Medication Solutions ziprasidone hydrochloride 50090-5785
Bryant Ranch Prepack ziprasidone hydrochloride 63629-3331
Bryant Ranch Prepack ziprasidone hydrochloride 63629-8150
NuCare PharmaceuticalsInc ziprasidone hydrochloride 68071-2979
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SULFOBUTYLETHER .BETA.-CYCLODEXTRIN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links